Hydroxyurea for the prevention of stroke and other vasoocclusive complications in children with sickle cell disease.

被引：0
|
作者：
Schmugge, M
Zurbriggen, K
Albisetti, M
Schmid, M
Baumgartner, RW
Sztajzel, R
Martin, G
Ozsahin, H
机构：
[1] Univ Childrens Hosp, Zurich, Switzerland
[2] Univ Hosp, Zurich, Switzerland
[3] Univ Hosp, Geneva, Switzerland
[4] Univ Childrens Hosp, Geneva, Switzerland
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3792
引用
收藏
页码：27B / 27B
页数：1
相关论文
共 50 条
  • [31] Stroke prevention in sickle cell disease
    Adams, RJ
    CURRENT OPINION IN HEMATOLOGY, 2000, 7 (02) : 101 - 105
  • [32] Hydroxyurea Use Is Associated with Avascular Necrosis of the Femoral Head among Children with Sickle Cell Disease.
    Mahadeo, Kris Michael
    Oyeku, Suzette
    Moody, Karen
    Rajpathak, Swapmil N.
    Groner, Abraham
    Santizo, Ruth
    Driscoll, M. Catherine
    BLOOD, 2008, 112 (11) : 860 - 861
  • [33] Does hydroxyurea prevent pulmonary complications of sickle cell disease?
    Buckner, Tyler W.
    Ataga, Kenneth I.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2014, : 432 - 437
  • [34] FRAGMENT D-DIMER LEVELS - AN OBJECTIVE MARKER OF VASOOCCLUSIVE CRISIS AND OTHER COMPLICATIONS OF SICKLE-CELL DISEASE
    DEVINE, DV
    KINNEY, TR
    THOMAS, PF
    ROSSE, WF
    GREENBERG, CS
    BLOOD, 1986, 68 (01) : 317 - 319
  • [35] Hydroxyurea (HU) for prevention of recurrent stroke in sickle cell anemia (SCA)
    Sumoza, A
    de Bisotti, R
    Sumoza, D
    Fairbanks, V
    AMERICAN JOURNAL OF HEMATOLOGY, 2002, 71 (03) : 161 - 165
  • [36] Hydroxyurea (HU) for prevention of recurrent stroke in sickle cell anemia (SCA).
    Sumoza, A
    Bisotti, R
    Gonzalez, S
    Costa, M
    Hernandez, M
    Pinto, S
    Sumoza, D
    Fairbanks, VF
    BLOOD, 1998, 92 (10) : 35B - 35B
  • [37] TCD with Transfusions Changing to Hydroxyurea (TWiTCH): Hydroxyurea Therapy As an Alternative to Transfusions for Primary Stroke Prevention in Children with Sickle Cell Anemia
    Ware, Russell E.
    Davis, Barry R.
    Schultz, William H.
    Brown, Clark
    Aygun, Banu
    Sarnaik, Sharada A.
    Odame, Isaac
    Fuh, Beng
    George, Alex
    Owen, William
    Luchtman-Jones, Lori
    Rogers, Zora R.
    Hilliard, Lee
    Gauger, Cynthia
    Piccone, Connie M.
    Lee, Margaret T.
    Kwiatkowski, Janet
    Jackson, Sherron
    Miller, Scott T.
    Roberts, Carla W.
    Heeney, Matthew M.
    Kalfa, Theodosia A.
    Nelson, Stephen C.
    Imran, Hamayun
    Nottage, Kerni A.
    Alvarez, Ofelia A.
    Rhodes, Melissa
    Thompson, Alexis A.
    Rothman, Jennifer
    Helton, Kathleen J.
    Roberts, Donna
    Coleman, Jamie
    Bonner, Melanie J.
    Kutlar, Abdullah
    Patel, Niren
    Wood, John C.
    Piller, Linda
    Wei, Peng
    Luden, Judy
    Mortier, Nicole A.
    Stuber, Susan
    Luban, Naomi L. C.
    Cohen, Alan R.
    Pressel, Sara L.
    Adams, Robert J.
    BLOOD, 2015, 126 (23)
  • [38] Hydroxyurea granules for the management of sickle cell disease in children
    Allotey-Babington, Grace Lovia
    Seaneke, Obedia Akwele
    Williams, Abigail Annan
    Asiedu, Esther Atiapa
    Amuakwa, Maxine Kelly
    Nettey, Henry
    SCIENTIFIC AFRICAN, 2022, 16
  • [39] Hydroxyurea and Growth in Young Children With Sickle Cell Disease
    Rana, Sohail
    Houston, Patricia E.
    Wang, Winfred C.
    Iyer, Rathi V.
    Goldsmith, Jonathan
    Casella, James F.
    Reed, Caroline K.
    Rogers, Zora R.
    Waclawiw, Myron A.
    Thompson, Bruce
    PEDIATRICS, 2014, 134 (03) : 465 - 472
  • [40] Predictors of Hydroxyurea Use in Children with Sickle Cell Disease
    Okwor, Chisom Ifeoma
    Klaassen, Robert J.
    Harrison, Mary-Ann
    Tang, Ken
    Laforest, Isabelle
    Bowerman, Brooke
    Simpson, Ewurabena
    BLOOD, 2018, 132
12345